Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 17.98B | 28.86B | 20.97B | 15.25B | 13.16B | 11.69B |
Gross Profit | 4.26B | 8.23B | 5.83B | 2.68B | 2.85B | 2.57B |
EBITDA | 2.31B | 6.13B | 3.91B | 1.16B | 1.03B | 909.01M |
Net Income | 1.44B | 4.33B | 2.55B | 808.85M | 539.99M | 323.48M |
Balance Sheet | ||||||
Total Assets | 15.30B | 32.96B | 25.00B | 20.42B | 17.41B | 16.88B |
Cash, Cash Equivalents and Short-Term Investments | 3.79B | 7.41B | 4.28B | 4.26B | 4.09B | 2.89B |
Total Debt | 2.85B | 4.74B | 3.21B | 2.65B | 3.85B | 4.09B |
Total Liabilities | 9.61B | 19.08B | 15.25B | 13.07B | 10.74B | 10.67B |
Stockholders Equity | 5.70B | 13.88B | 9.75B | 7.34B | 6.67B | 6.21B |
Cash Flow | ||||||
Free Cash Flow | 1.05B | 2.41B | -378.62M | 1.44B | 1.45B | -1.14B |
Operating Cash Flow | 1.05B | 6.75B | 391.13M | 2.50B | 1.71B | -76.45M |
Investing Cash Flow | 0.00 | -4.70B | -761.91M | -1.06B | -269.51M | -1.06B |
Financing Cash Flow | 0.00 | 1.08B | 389.47M | -1.26B | -247.81M | 144.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥57.42B | 13.26 | 1.52% | 37.64% | 69.78% | ||
77 Outperform | ¥88.90B | 10.57 | 3.78% | -1.05% | -23.08% | ||
76 Outperform | $54.81B | 11.93 | 11.87% | 2.32% | 8.57% | 11.11% | |
75 Outperform | ¥92.94B | 17.60 | 5.29% | 0.68% | -32.97% | ||
74 Outperform | ¥54.37B | 13.54 | 2.90% | 6.66% | -34.82% | ||
71 Outperform | ¥254.47B | 13.17 | 8.49% | 3.06% | 6.31% | 13.07% | |
62 Neutral | ¥9.76B | 18.20 | 2.32% | 15.54% | -47.78% |